One Gram of Aspirin Per Day Does Not Reduce Risk of Hospitalization for Gallstone Disease

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 1991 Aug 1

PMID 1864205

Citations 5

Authors

J H Kurata

J Marks

D Abbey

Affiliations

Soon will be listed here.

Abstract

Data from 4524 patients in a randomized, controlled trial of aspirin were analyzed to determine if aspirin reduced the risk for hospitalization for gallstone disease. Aspirin at a dose of 1000 mg/day did not reduce the risk of hospitalization for gallstones. Hospitalization rates for gallstone disease were consistent with national rates, and the data confirmed previous associations of gallstone disease with age, elevated serum triglycerides, obesity, and female gender.

Citing Articles

The inflammatory inception of gallbladder cancer.

Espinoza J, Bizama C, Garcia P, Ferreccio C, Javle M, Miquel J Biochim Biophys Acta. 2016; 1865(2):245-54.

PMID: 26980625 PMC: 6287912. DOI: 10.1016/j.bbcan.2016.03.004.

Body mass index, abdominal fatness and the risk of gallbladder disease.

Aune D, Norat T, Vatten L Eur J Epidemiol. 2015; 30(9):1009-19.

PMID: 26374741 DOI: 10.1007/s10654-015-0081-y.

Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.

Maurer K, Carey M, Fox J Gastroenterology. 2008; 136(2):425-40.

PMID: 19109959 PMC: 2774219. DOI: 10.1053/j.gastro.2008.12.031.

Cholelithiasic disease and associated factors in a Spanish population.

Devesa F, Ferrando J, Caldentey M, Borghol A, Moreno M, Nolasco A Dig Dis Sci. 2001; 46(7):1424-36.

PMID: 11478494 DOI: 10.1023/a:1010631619162.

Effect of NSAIDs on gallbladder bile composition.

Sterling R, Shiffman M, Sugerman H, Moore E Dig Dis Sci. 1995; 40(10):2220-6.

PMID: 7587793 DOI: 10.1007/BF02209010.

References

Goldman G, Kahn P, Alon R, WIZNITZER T . Biliary colic treatment and acute cholecystitis prevention by prostaglandin inhibitor. Dig Dis Sci. 1989; 34(6):809-11. DOI: 10.1007/BF01540262. View

Friedman G, Kannel W, DAWBER T . The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis. 1966; 19(3):273-92. DOI: 10.1016/0021-9681(66)90132-9. View

Laakso M, Suhonen M, Julkunen R, Pyorala K . Plasma insulin, serum lipids and lipoproteins in gall stone disease in non-insulin dependent diabetic subjects: a case control study. Gut. 1990; 31(3):344-7. PMC: 1378281. DOI: 10.1136/gut.31.3.344. View

Scragg R, McMichael A, Baghurst P . Diet, alcohol, and relative weight in gall stone disease: a case-control study. Br Med J (Clin Res Ed). 1984; 288(6424):1113-9. PMC: 1441375. DOI: 10.1136/bmj.288.6424.1113. View

. The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). Hepatology. 1988; 8(4):907-13. View

Bennion L, Grundy S . Risk factors for the development of cholelithiasis in man (second of two parts). N Engl J Med. 1978; 299(22):1221-7. DOI: 10.1056/NEJM197811302992205. View

Broomfield P, Chopra R, Sheinbaum R, Bonorris G, Silverman A, SCHOENFIELD L . Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med. 1988; 319(24):1567-72. DOI: 10.1056/NEJM198812153192403. View

SCHOENBERGER J . Recruitment experience in the Aspirin Myocardial Infarction Study. Control Clin Trials. 1987; 8(4 Suppl):74S-78S. DOI: 10.1016/0197-2456(87)90009-2. View

Hood K, Gleeson D, Ruppin D, Dowling R . Prevention of gallstone recurrence by non-steroidal anti-inflammatory drugs. Lancet. 1988; 2(8622):1223-5. DOI: 10.1016/s0140-6736(88)90812-4. View

10.

Kadziolka R, Nilsson S, Schersten T . Prevalence of hyperlipoproteinemia in men with gallstone disease. Scand J Gastroenterol. 1977; 12(3):353-5. DOI: 10.3109/00365527709180940. View

11.

Lamont J, Turner B, Dibenedetto D, Handin R, Schafer A . Arachidonic acid stimulates mucin secretion in prairie dog gallbladder. Am J Physiol. 1983; 245(1):G92-8. DOI: 10.1152/ajpgi.1983.245.1.G92. View

12.

Lee S, Carey M, Lamont J . Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science. 1981; 211(4489):1429-31. DOI: 10.1126/science.7466399. View

13.

Frost P, Verter J, Miller D . Serum lipids and lipoproteins after myocardial infarction: associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction Study. Am Heart J. 1987; 113(6):1356-64. DOI: 10.1016/0002-8703(87)90648-x. View

14.

Scragg R, Calvert G, Oliver J . Plasma lipids and insulin in gall stone disease: a case-control study. Br Med J (Clin Res Ed). 1984; 289(6444):521-5. PMC: 1442729. DOI: 10.1136/bmj.289.6444.521. View

15.

Pixley F, Wilson D, McPherson K, Mann J . Effect of vegetarianism on development of gall stones in women. Br Med J (Clin Res Ed). 1985; 291(6487):11-2. PMC: 1416200. DOI: 10.1136/bmj.291.6487.11. View

16.

Barbara L, Sama C, Morselli Labate A, Taroni F, Rusticali A, Festi D . A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology. 1987; 7(5):913-7. DOI: 10.1002/hep.1840070520. View

17.

Smith B, Lamont J . The pathogenesis of gallstones. Hosp Pract (Off Ed). 1984; 19(12):93-9, 103-4. DOI: 10.1080/21548331.1984.11702958. View

18.

. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA. 1980; 243(7):661-9. View